The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
Abstract
Long-term treatment with glucocorticoids (GCs) leads to a rapid bone loss and to a greater risk of fractures. To evaluate the specific effects of this treatment on cancellous bone remodeling, structure, and microarchitecture, we compared 22 transiliac biopsy specimens taken in postmenopausal women (65 ± 6 years) receiving GCs (≥7.5 mg/day, for at least 6 months) and 22 biopsy specimens taken in age-matched women with postmenopausal osteoporosis (PMOP), all untreated and having either at least one vertebral fracture or a T score < −2.5 SD. On these biopsy specimens, we measured static and dynamic parameters reflecting trabecular bone formation and resorption. Also, we performed the strut analysis and evaluated the trabecular bone pattern factor (TBPf), Euler number/tissue volume (E/TV), interconnectivity index (ICI), and marrow star volume (MaSV). Glucocorticoid-induced osteoporosis (GIOP), when compared with PMOP, was characterized by lower bone volume (BV/TV), trabecular thickness (Tb.Th), wall thickness (W.Th), osteoid thickness (O.Th), bone formation rate/bone surface (BFR/BS), adjusted mineral apposition rate/bone surface (Aj.AR/BS), and higher ICI and resorption parameters. After adjustment for BV/TV, the W.Th remained significantly lower in GIOP (p < 0.0001). The active formation period [FP(a+)] was not different. Patients with GIOP were divided into two groups: high cumulative dose GCs (HGCs; 23.7 ± 9.7 g) and low cumulative dose GCs (LGCs; 2.7 ± 1.2 g). HGC when compared with LGC was characterized by lower W.Th (p < 0.05), BV/TV (p < 0.001), Tb.Th (p < 0.05), trabecular number (Tb.N; p < 0.05), FP(a+) (p < 0.05), and nodes (p < 0.05), and higher E/TV (p < 0.05), ICI (p < 0.005), and TBPf (p < 0.05). When HGC was compared with PMOP, the results were similar except for the MaSV, which was significantly higher (p < 0.005). In summary, GIOP was characterized by lower formation and higher resorption than in PMOP, already present after LGC. With HGCs, these changes were associated with a more dramatic bone loss caused by a major loss of trabecular connectivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the skeletal response to prednisolone in these rats shared several similarities to changes observed in humans, including significantly decreased BMD (243), histological evidence of increased bone resorption (194), and biochemical evidence of suppressed bone formation (244, 267, 268).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [194]
In the citing paper
“The prednisolonerelated increase in bone volume in rats, confirmed in a study described immediately below (262), is not consistent with histological data from patients with glucocorticoid-induced osteoporosis (194) and is a recognized limitation of the model (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [194]
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationPARFITT, A. M., Mathews, C. H. E., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,542
The direct examination of three-dimensional bone architecture in vitro by computed tomography
Feldkamp, L. A., Goldstein, S. A., Parfitt, M. A., Jesion, G., & Kleerekoper, M. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040103 · Cited by 1,073
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,063
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 662
Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture
Hahn, M. P., Vogel, M., Pompesius-Kempa, M., & Delling, G. (1992) · Bone · doi:10.1016/8756-3282(92)90078-b · Cited by 540
Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis
Laan, R., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., Hof, M. A. V., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 410
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
New Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis
Manolagas, S. C., & Weinstein, R. S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1061 · Cited by 382
Research works printed but not linked: 2
- Le, 1992, Computerized quantitative analysis of the interconnectivity of porous biomaterials, Acta Stereol, 11, 267
- Gallagher, 1996, Osteoporosis, 1191
Cited by
Sorted by citations
Items 201–300 of 308
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats
Carbonare, L. D., Bertoldo, F., Valenti, M. T., Zordan, S., Sella, S., Fassina, A., Turco, G., Realdi, G., Cascio, V. L., & Giannini, S. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03350811 · Cited by 10
Self-citationSchulz, M. C., Kowald, J., Estenfelder, S., Jung, R., Kuhlisch, E., Eckelt, U., Mai, R., Hofbauer, L. C., Stroszczynski, C., & Stadlinger, B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00426 · Cited by 10
Bone Histomorphometry -- The Renaissance?
Compston, J. E. (2004) · BoneKEy-Osteovision · doi:10.1138/20040129 · Cited by 10
Weiler, U., Finsler, S., & Claus, R. (2003) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1046/j.1439-0442.2003.00493.x · Cited by 10
Jaw Bone Samples From Bisphosphonate‐Treated Patients: A Pilot Cohort Study
Cardemil, C., Thomsen, P., & Wexell, C. L. (2015) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12307 · Cited by 9
Drug and Hormone Effects on Vitamin D Metabolism
Epstein, S., & Schneider, A. E. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50077-2 · Cited by 9
Diagnostic et traitement de l'ostéoporose juvénile
Cimaz, R., & Guez, S. (2005) · Archives de Pédiatrie · doi:10.1016/j.arcped.2005.02.007 · Cited by 9
Trabecular bone microarchitecture in mild primary hyperparathyroidism
Carbonare, L. D., Ballanti, P., Bertoldo, F., Valenti, M. T., Giovanazzi, B., Giannini, S., Realdi, G., & Cascio, V. L. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346402 · Cited by 9
Self-citationIncidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?
Devogelaer, J. P. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450237 · Cited by 9
Lim, Y., Baek, K. H., Kim, H., Lee, S., Lee, J. W., & Kang, M.-I. (2019) · Bone · doi:10.1016/j.bone.2019.04.004 · Cited by 8
Mechanisms and therapeutics of glucocorticoid-induced osteoporosis.
Kaneko, K., & Kawai, S. (2011) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.34.138 · Cited by 8
Ma, H., Zhou, D., Li, D., Zhang, W., & Zeng, B. (2017) · Journal of Physical Therapy Science · doi:10.1589/jpts.29.24 · Cited by 8
Updated recommendations on the management of glucocorticoid-induced osteoporosis
Orcel, P. (2014) · Joint Bone Spine · doi:10.1016/j.jbspin.2014.08.004 · Cited by 8
Antiosteoporosis and bone protective effect of nimbolide in steroid‐induced osteoporosis rats
Huo, J., Ding, Y., Wei, X., Chen, Q., & Zhao, B. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23209 · Cited by 7
Beyond the Surface: Uncovering Secondary Causes of Osteoporosis for Optimal Management
Hosein‐Woodley, R., Hirani, R., Issani, A., Hussaini, A. S., Stala, O., Smiley, A., Etienne, M., & Tiwari, R. K. (2024) · Biomedicines · doi:10.3390/biomedicines12112558 · Cited by 8
Jeong, Y.-H., Hur, H. J., Lee, A. S., Lee, S. E., & Sung, M. J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1927017 · Cited by 7
Henning, P., Conaway, H. H., & Lerner, U. H. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.04.005 · Cited by 8
Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
Bioletto, F., Barale, M., Parasiliti‐Caprino, M., Giannelli, J., Campioni, L., Cappiello, V., Carlo, M. C. D., Ghigo, E., Massimo, P., & Giordano, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234237 · Cited by 7
Bone Histomorphometry in Untreated and Treated Glucocorticoid-Induced Osteoporosis
Carbonare, L. D., Chavassieux, P., ARLOT, M. E., & Meunier, P. J. (2002) · KARGER eBooks · doi:10.1159/000061069 · Cited by 7
Self-citationAndreasen, C. M., Ding, M. L., Andersen, T. L., & Overgaard, S. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2447 · Cited by 7
Lamarche, B. A., Thomsen, J. S., Andreasen, C. M., Andersen, T. L., & Lievers, W. B. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae143 · Cited by 6
So, H., Griffith, J. F., Lau, S.-L., Hung, V. W. Y., Lee, V. K. L., Kwok, K. Y., Ying, S. K. Y., Lee, J. J. W., Chan, C. Y., Qin, L., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.11.001 · Cited by 6
Identification of patient profile for treatment
Moon, R. J., & Harvey, N. C. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.04.005 · Cited by 6
Lokale und systemische Knocheneffekte bei rheumatoider Arthritis
Rauner, M., Hofbauer, L. C., & Aringer, M. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0927-y · Cited by 7
Sarker, H., Hardy, E., Haimour, A., Karim, M. A., Scholl‐Bürgi, S., Martignetti, J. A., Botto, L. D., & Fernández-Patrón, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568718 · Cited by 6
Glucocorticoid-induced osteoporosis
Sambrook, P. N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00198-6 · Cited by 6
Makras, P., Piaditis, G. P., & Kaltsas, G. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.6.773 · Cited by 6
Hydrocortisone increases the rate of differentiation of cultured human osteoblasts
Ireland, D. C., Bord, S., Beavan, S. R., & Compston, J. E. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10756 · Cited by 6
Osteoporose e erosões osseas focais na artrite reumatóide: da patogênese ao tratamento
Pereira, I. A., & Pereira, R. M. R. (2004) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042004000500006 · Cited by 6
Glucocorticoid-induced Osteoporosis; Update
Kim, S., & Kim, H. J. (2009) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2009.44.2.151 · Cited by 6
Sun, X., Wu, Y., Lü, L., Xia, W., Zhang, L., Chen, S., Nie, M., Zheng, G., Su, W., Zhu, H., et al. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01132-w · Cited by 5
Trabecular Bone Score to Enhance Fracture Risk Prediction and Treatment Strategies in Osteoporosis
Gatineau, G., Hans, D. B., & Hind, K. (2024) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-0044-1788886 · Cited by 5
Wang, K., Zhu, Z., Wang, B., Zhu, Y., & Liu, H. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0561-y · Cited by 5
The Effects of Skimmed Milk, Soybean Flour and Sardine Fish Powder on Osteoporotic Female Rats
Soltan, S. S. A. (2013) · Cited by 5
The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood
Cimaz, R., & Ward, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00053-3 · Cited by 5
Fractal-Based Analysis of Bone Microstructure in Crohn’s Disease: A Pilot Study
Haschka, J., Kraus, D. A., Behanová, M., Huber, S., Bartko, J., Schanda, J. E., Meier, P., Bahrami, A., Zandieh, S., Zwerina, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124116 · Cited by 5
Histologic diagnosis of metabolic bone diseases: bone histomorphometry
Carbonare, L. D., & Giannini, S. (2011) · Reumatismo · doi:10.4081/reumatismo.2004.15 · Cited by 5
Self-citationHatano, M., Kitajima, I., Nakamura, M., Isawa, K., Suwabe, T., Hoshino, J., Kinowaki, K., Ohashi, K., Sawa, N., Yamamoto, S., et al. (2021) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxab028 · Cited by 5
Rizzoli, R. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0838 · Cited by 5
SKELETAL MATURATION AND BONE MINERALIZATION IN THE PEDIATRIC RHEUMATIC DISEASES
Cimaz, R., & Falcini, F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10049-4 · Cited by 5
Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment
Gelardi, M., Barbara, F., Covelli, I., Damiani, M., Plantone, F., Notarnicola, A., Moretti, B., Quaranta, N. A. A., & Ciprandi, G. (2018) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-018-1466-5 · Cited by 4
Prophylaxe und Therapie der Glukokortikoid-induzierten Osteoporose – rezente Leitlinien im Überblick
ÖGR), (. O. D. Ö. G. F. R. U. R. –., Rintelen, B., Bobacz, K., Höfle, G., Peichl, P., Rainer, F., Weber, K., & Gaugg, M. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0042-8 · Cited by 4
First meeting on bone quality, Abbaye des Vaux de Cernay, France, 15–16 June 2006: Bone architecture
(2007) · Osteoporosis International · doi:10.1007/s00198-007-0366-4 · Cited by 5
Drug and Hormone Effects on Vitamin D Metabolism
Weinstein, B. M., & Epstein, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10067-8 · Cited by 3
Bone Microarchitecture in Osteoporotic Men: Information Incomplete
Legrand, É., & Audran, M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.7.1375 · Cited by 3
Camozzi, V., Carraro, V., Zangari, M., Fallo, F., Mantero, F., & Luisetto, G. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347471 · Cited by 3
Camozzi, V., Luisetto, G., Zangari, M., & Lumachi, F. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.032 · Cited by 3
Migita, K., Iwanaga, N., Imadachi, S., Jiuchi, Y., Izumi, Y., Tsuji, Y., Kawahara, C., Kawakami, A., Furukawa, H., & Tohma, S. (2015) · Medicine · doi:10.1097/md.0000000000000875 · Cited by 3
Elmorsy, E. M., Al-Ghafari, A. B., Doghaither, H. A. A., Almaghrabi, R. O., Ibrahim, S. F., Othman, G., Ibrahim, A. M., & Abdeen, A. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115573 · Cited by 2
Palliative therapy of osteochondrosis dessicans in a Duroc boar.
Oomah, K. (2008) · PubMed Central · Cited by 2
Wang, L., Gao, W., Xiong, K., Liu, N., & Wang, B. (2012) · Europe PMC (PubMed Central) · Cited by 2
Golovach, I. Y. (2019) · PAIN JOINTS SPINE · doi:10.22141/2224-1507.9.4.2019.191923 · Cited by 2
Glucocorticoid-Induced Bone Loss in Children
Klein, G. L. (2004) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-004-0011-0 · Cited by 2
Efeito do extrato de Ginkgo biloba L., Ginkgoaceae, na osteoporose induzida em ratas Wistar
Lucinda, L. M. F., Vieira, B. J., Salvador, P. A., de Oliveira, T. T., Peters, V. M., Reis, J. E. D. P., & Guerra, M. D. O. (2010) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2010000300022 · Cited by 2
Valta, H. (2009) · Työväentutkimus Vuosikirja · Cited by 2
Jamil, A. J. M., Madsen, K., Daamouch, S., Villadsen, B., Ma, C., Jeromdesella, S., Nørgård, M. Ø., Grupe, E., Jakobsson, M. B., Wang, Y., et al. (2026) · Bone Research · doi:10.1038/s41413-026-00536-2 · Cited by 1
Kannan, A. S., Minardi, S., Ellenbogen, D. J., Hallman, M. J., Greene, A. C., Yamaguchi, J. T., Plantz, M. A., Jeong, S., Sana, K., Shah, V. P., et al. (2021) · JOR Spine · doi:10.1002/jsp2.1177 · Cited by 1
Rauch, A., Baschant, U., & Tuckermann, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5366-6_5 · Cited by 1
OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Seredavkina, N. V., & Reshetnyak, T. M. (2009) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2009-575 · Cited by 1
Risk Factors for Low Bone Mineral Density in Korean Patients with Systemic Lupus Erythematosus
Park, Y., Park, B.-H., Min, D., & Kim, W. (2011) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2011.18.1.19 · Cited by 1
Biochemische Marker des Knochenstoffwechsels nach Osteotomie Das Schaf als Osteoporosemodell
der Ludwig-Maximilians-Universität, F., & Rambeck, W. A. (2007) · Cited by 1
Surgical Intervention for Rheumatoid Arthritis and Complication Risks
Lee, M. H., George, D. A., Khor, S., Elvey, M., & Rashid, A. (2018) · Technical report · doi:10.1016/b978-0-444-63887-8.00006-2 · Cited by 1
Sato, H., Kondo, N., Kurosawa, Y., Hasegawa, E., Wakamatsu, A., Kobayashi, D., Nakatsue, T., Kazama, J. J., Kuroda, T., Suzuki, Y., et al. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-021-01244-z · Cited by 1
Soliman, T. M., Ali, Z., Zayed, M. A., Sabry, D., & AbuBakr, N. (2021) · Brazilian Dental Science · doi:10.4322/bds.2021.e2876 · Cited by 1
Sambrook, P. N. (2002) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v31n1p48 · Cited by 1
Prévention et traitement de l’ostéoporose cortico-induite
Roux, C. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72575-6 · Cited by 1
Glucocorticoid osteoporosis - relations to BMU theory and to bone cell birth and death
PARFITT, A. M. (2001) · BoneKEy-Osteovision · doi:10.1138/2001026 · Cited by 1
SKELETAL MATURATION AND BONE MINERALIZATION IN THE PEDIATRIC RHEUMATIC DISEASES
Cimaz, R., & Falcini, F. (2005) · Elsevier eBooks · doi:10.1016/b978-1-4160-0246-8.50044-9 · Cited by 1
Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid ExcessPreprint
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Yano, S., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4178844 · Cited by 1
Osteoporosi nel paziente sottoposto a trapianto d’organo
Giannini, S., Sella, S., & Carbonare, L. D. (2004) · L Endocrinologo · doi:10.1007/bf03344485
Self-citationGlucocorticoid action in osteoblasts
Kido, S., 井上, 大., & 松本, 俊. (2004) · ホルモンと臨牀
Generalized Skeletal Abnormalities
Castriota-Scanderbeg, A. (2005) · Springer eBooks · doi:10.1007/3-540-30361-8_9
Glucocorticoid-Induced Osteoporosis
Ćurković, B. (2007) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/v10004-007-0004-8
Traitement médicamenteux des ostéoporoses post-ménopausiques et cortisoniques
Roux, C. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00426-x
Ostéoporose cortico-induite : données physiopathologiques et thérapeutiques récentes
Lafage‐Proust, M., Boudignon, B. M., & Thomas, T. (2003) · Revue du Rhumatisme · doi:10.1016/s1169-8330(03)00059-0
Actualisation des recommandations pour la prise en charge de l’ostéoporose cortisonique
Orcel, P. (2014) · Revue du Rhumatisme · doi:10.1016/j.rhum.2014.08.004
Mahl, C. R. W. (2007) · Americanae (AECID Library)
Effect of systemic glucocorticoid therapy on bone metabolism: an update
Cooper, M. S. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.111
Osteoporosis secundaria a tratamiento con glucocorticoides
Escalada, J. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)70993-1
Avaliação da composição corporal e densidade mineral ósseo em mulheres com artrite reumatóide
da Silva, R. G. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-31052007-165929
Recker, R. R., Reid, D. M., Papanastasiou, P., & Chappard, D. (2011) · Bone · doi:10.1016/j.bone.2011.03.466
Rehabilitation in Patients with Inflammatory Bowel Disease and Familial Adenomatous Polyposis
Lipanje, F., Colucci, G., & Delaini, G. G. (2006) · Springer eBooks · doi:10.1007/88-470-0434-9_50
Vukmirović-Popović, S., Seidlitz, E. P., Orr, F. W., & Singh, G. (2004) · Cancer metastasis · doi:10.1007/978-1-4020-2036-0_3
Kertmen, N., & Yıldız, M. (2015) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.v37i4.5000161253
[Glucocorticoid-induced osteoporosis].
Fołtyn, W., Kos‐Kudła, B., Marek, B., Kajdaniuk, D., Joanna, G. D., Siemiæska, L., Strzelczyk, J., & Borowska, M. (2007) · PubMed
Álvarez‐Álvarez, L., Monegal, A., Peris, P., Riba, J., & Ercilla, G. (2004)
The Pathogenesis of Glucocorticoid-Induced Bone Loss
Devogelaer, J.-P., Boutsen, Y., & Manicourt, D. H. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50028-2
Glucocorticoid‐induced Osteoporosis
Silverman, S. L., & Venuturupalli, S. (2013) · Wiley eBooks · doi:10.1002/9781118316290.ch6
Biomarkers in real-life COPD Management
Oshagbemi (2019) · doi:10.26481/dis.20191202oo
Hagag, T. A. E. K., Mahmoud, E. F., Mahmoud, M. F., & Salem, Z. A. (2019) · Journal of Dentistry Indonesia · doi:10.14693/jdi.v26i3.1039
Bone Densitometry in a Cohort of Egyptian Children with Steroid Sensitive Nephrotic Syndrome.
Makar, S. H., Ali, E., Kenany, M. E., & Salah, D. M. (2020) · GEGET · doi:10.21608/geget.2020.23447.1012
The Role of Parathyroid Hormone in the Evolution of Bone Loss after Organ Transplantation
Rubin, M. R., & Bilezikian, J. P. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50010-9
Skeletal Effects of Glucocorticoids: Basic and Clinical Aspects
CANALIS, E. M. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50004-3
Glucocorticoids and Musculoskeletal Health
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_31
Matsumoto, T. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717976398.793471809
An inconvenient status in anti-osteoporotic treatment process: corticosteroid use
Öztürk, E., Çiğiloğlu, A., Çakmak, G., & Öztürk, Z. A. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20211368
Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid ExcessPreprint
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., Trada, E., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4089144
Sarraj, M., Saidahmed, A., Thornley, P., Koziarz, F., Khamis, R. A., Jentzsch, T., Bhanot, K., & Oitment, C. T. A. (2023) · Spine Surgery and Related Research · doi:10.22603/ssrr.2022-0187
Metadata
- Authors
- Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J.
- Affiliations
- Inserm (FR)
- Institut National de la Santé et de la Recherche Médicale Unit 403 and Laboratoire d'Histodynamique Osseuse, Lyon, France
- Corresponding author
- Carbonare, L. Dalle
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 16
- Issue
- 1
- Pages
- 97-103
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1972567404
- Cited by
- 309
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 13 · 2019: 11 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 12 · 2014: 12 · 2013: 12 · 2012: 16
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoid-induced osteoporosis, postmenopausal osteoporosis, trabecular bone microarchitecture, bone remodeling, trabecular bone, bone formation rate, bone resorption, cumulative glucocorticoid dose, bone loss, trabecular thickness, wall thickness, Euler characteristic
- MeSH terms
- Aged, Biopsy, Bone and Bones, Female, Glucocorticoids, Histocytochemistry, Humans, Ilium, Middle Aged, Osteoporosis, Osteoporosis, Postmenopausal, Bone Remodeling, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review